UniProt O00585
C-C motif chemokine 21 (O00585)
C-C motif chemokine 21 (UniProt O00585): 4 experimental structures and 1 predicted model on GenesisL1, 1 ligand bound, 24 pockets. Binding sites, druggability and experiment against prediction (TM-score) in GL1X.
- UniProt
- O00585
- Protein
- C-C motif chemokine 21
- Experimental structures
- 4
- Predicted models
- 1
- Ligands
- 1
- Pockets
- 24 · 2 records with a druggable one
Structures
5 records of O00585 in the MolNFT archive: 4 experimental, 1 predicted.
| Entry | Title | Method | Chains | Ligands | Pockets |
|---|---|---|---|---|---|
| 2L4N | Solution Structure of the Chemokine CCL21 | solution nmr | A | — | — |
| 2L4N | Solution structure of the chemokine CCL21 | solution nmr | A | — | — |
| 5EKI | Crystal Structure of Truncated CCL21 | x-ray diffraction | A, B, C, D, E, F | SO4 | 12 (best 0.53) |
| 5EKI | Crystal structure of truncated CCL21 | x-ray diffraction | A, B, C, D, E, F | SO4 | 12 (best 0.53) |
| O00585 | AlphaFold monomer V2.0 prediction for C-C motif chemokine 21 (O00585) | predicted | A | — | — |
Ligands
- SO4 · Sulfate ion · in 2 records
Experiment against prediction
- 5EKI chain A against the predicted model O00585: TM-score 0.93, RMSD 0.94 Å
- 5EKI chain A against the predicted model O00585: TM-score 0.93, RMSD 0.94 Å
- 5EKI chain B against the predicted model O00585: TM-score 0.93, RMSD 0.94 Å
- 5EKI chain B against the predicted model O00585: TM-score 0.93, RMSD 0.94 Å
- 5EKI chain E against the predicted model O00585: TM-score 0.93, RMSD 0.95 Å
- 5EKI chain E against the predicted model O00585: TM-score 0.93, RMSD 0.95 Å
- 5EKI chain D against the predicted model O00585: TM-score 0.93, RMSD 0.95 Å
- 5EKI chain D against the predicted model O00585: TM-score 0.93, RMSD 0.95 Å
- 5EKI chain F against the predicted model O00585: TM-score 0.93, RMSD 1.03 Å
- 5EKI chain F against the predicted model O00585: TM-score 0.93, RMSD 1.03 Å
Elsewhere
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.